Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current BM8 market cap is 11.8B. The company's latest EPS is USD 0.8796 and P/E is 73.76.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 1.7B | 1.86B | 1.85B | 2.1B | 2.42B |
| Operating Income | -126.04M | -96.27M | -20.41M | 41.56M | 185.8M |
| Net Income | -23.85M | 859.1M | -2.15M | 141.56M | 167.65M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 4.69B | 5.85B | 6B | 6.38B | 6.84B |
| Total Liabilities | 1.57B | 1.74B | 1.73B | 1.77B | 1.89B |
| Total Equity | 3.12B | 4.11B | 4.27B | 4.6B | 4.95B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 48.26M | 85.37M | 304.54M | 175.9M | 159.26M |
| Investing | -31.03M | -53.62M | -366.31M | -20.03M | -111.24M |
| Financing | -74.67M | 181.12M | -48k | -18.65M | -18.73M |
| Market Cap | 11.8B |
| Price to Earnings Ratio | 73.76 |
| Price to Sales Ratio | 5.11 |
| Price to Cash Ratio | 16.37 |
| Price to Book Ratio | 2.5 |
| Dividend Yield | - |
| Shares Outstanding | 190.58M |
| Average Volume (1 week) | 138 |
| Average Volume (1 Month) | 190 |
| 52 Week Change | -23.73% |
| 52 Week High | 90.60 |
| 52 Week Low | 57.92 |
| Spread (Intraday) | 0.28 (0.45%) |
| Company Name | Biomarin Phar Dl 001 |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.biomarin.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
